340B Fight Escalates: Tampa General Sues Eli Lilly
Supply Chain Pulse — 2026-07-09
Tampa General Hospital is suing Eli Lilly for withholding 340B discounts — a move that signals the drug manufacturer's claims-data standoff is no longer a negotiating tactic, it's a litigation trigger. That fight lands the same week CMS is attempting to claw back nearly $8 billion from providers tied to a 2022 Supreme Court ruling on 340B payment rates, making this the program's most turbulent stretch in years. Meanwhile, a wave of M&A — Allegheny swallowing Heritage Valley, Ascension outbidding HCA for Williamson Health, HCA offloading 31 post-acute locations — is quietly redrawing the health system map in ways that will reshape purchasing leverage and contract structures for supply chain teams. If you haven't audited your 340B compliance posture and vendor relationships lately, today is a good day to start.
Tampa General Sues Eli Lilly Over 340B Discount Freeze
Tampa General Hospital has filed suit against Eli Lilly after the pharma giant withheld 340B discounts from hospitals that refused to share claims data — a condition the 340B statute doesn't require. For supply chain and pharmacy teams, this is a direct threat to drug acquisition budgets: losing 340B pricing on a high-cost Lilly portfolio (think GLP-1s and oncology drugs) can mean seven-figure annual losses for a single covered entity.
Why the 340B Payment Fight Is Flaring Up Again
Following a 2022 Supreme Court ruling that CMS had unlawfully cut 340B reimbursement rates, the government is now attempting to recoup nearly $8 billion in payments it made to providers during the legal dispute — essentially asking hospitals to give back money they were owed. Supply chain and finance leaders at 340B-covered entities should be coordinating with legal and compliance now to understand their exposure, as CMS's proposed outpatient rule would set the stage for this clawback.
Allegheny Health Network Closes Deal to Buy Heritage Valley
Allegheny Health Network has completed its acquisition of Heritage Valley, adding two hospitals and approximately 500 physicians to its footprint — along with court-imposed conditions that will govern how the combined system operates. For regional suppliers and GPO contract holders, a network this size crossing a new geographic threshold often triggers contract renegotiations and supply standardization initiatives worth watching.
Ascension Outbids HCA and Optum for Williamson Health
Ascension won a competitive bidding process for Williamson Health, a Franklin, Tennessee hospital that drew interest from heavyweights HCA and Optum — a sign that non-profit systems are willing to move aggressively in high-growth suburban markets. Supply chain professionals should note that Ascension's integration playbook typically involves rapid standardization to its national GPO agreements, which will affect local and regional vendors currently contracted with Williamson.
HCA to Sell 31 Home Health and Hospice Locations to Deaconess
HCA Healthcare is divesting 31 home health and hospice sites to Deaconess in a deal expected to close within months pending regulatory approval. For supply chain teams at either organization, this kind of post-acute divestiture typically triggers a full inventory and vendor contract reconciliation — and for Deaconess, it means rapidly scaling a procurement infrastructure to support a significantly larger post-acute footprint.
ResMed Sells MatrixCare Software Business for $490M — Less Than a Decade After Paying $750M
ResMed is selling its MatrixCare long-term care software platform to PE firm Frazier Healthcare Partners for $490 million, taking a significant loss on the $750 million it paid in 2016 as it refocuses on its core sleep and respiratory device business. For supply chain teams using MatrixCare for care coordination or inventory management in post-acute settings, a PE ownership transition typically brings platform uncertainty and pricing pressure worth monitoring over the next 12–18 months.
Source: Medical Device Network
GTCR Divests Corza Medical Biosurgery Unit to EQT
Private equity firm GTCR is selling Corza Medical's biosurgery business unit to EQT in a deal that moves a key hemostatic and wound care product portfolio to new ownership. Biosurgery is a category where supply chain teams often have thin supplier redundancy, so a PE-to-PE ownership change warrants a check on contract continuity, pricing guarantees, and any planned SKU rationalization under the new ownership.
Source: GDELT - Healthcare Supply Chain
Layoffs and Closures Tracker: Dignity Health Cuts 139 Employees
Dignity Health has laid off 139 employees in the latest wave of healthcare workforce reductions hitting systems nationwide. Workforce cuts at this scale frequently precede or accompany supply chain restructuring, including GPO renegotiations, department consolidations, and vendor rationalization — worth tracking if Dignity is a key customer or partner in your network.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe